Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial is a research paper published in Obesity (2022). On theSindex it has a DataRank of 4.1. It has been cited 122 times, with 99 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.722
From this paper's citation signal
Citation Network Contribution
3.4
From 72 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 99 citers.
Center for Clinical and Translational Science, Mayo Clinic
Grant: UL1‐TR000135
National Institutes of Health
Grant: R01‐DK67071
NCATS NIH HHS
Grant: UL1 TR000135
NIDDK NIH HHS
Grant: R01 DK067071
National Institutes of Health
Grant: 5UL1TR000135-08
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
National Institutes of Health
Grant: 5R01DK067071-15
Effects of Liraglutide on Gastric Functions and their Relationship to Weight Loss in Obesity
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals